Lokelma

Chemical Namesodium zirconium cyclosilicate
Dosage FormSuspension (oral; 5 g, 10 g)
Drug ClassPotassium binders
SystemBlood
CompanyAstraZeneca
Approval Year2018

Indication

  • Lokelma is indicated for the treatment of hyperkalemia in adults.
Last updated on 6/11/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Clinical practice guidelines: treatment of acute hyperkalaemia in adults.2019The Renal Association